Clinical Trials Logo

Fecal Microbiota Transplantation clinical trials

View clinical trials related to Fecal Microbiota Transplantation.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04078581 Withdrawn - Clinical trials for Fecal Microbiota Transplantation

Profiling Fecal Samples for Selection of Donors of Feces

PROFIT
Start date: March 2020
Phase: N/A
Study type: Interventional

Fecal microbiota transplantation (FMT) represents a promising therapeutic in numerous clinical situations associated with dysbiosis. Today, this procedure is recommended in patients with recurrent Clostridioides difficile infections but beneficial effects of FMT have also been described in other diseases associated with intestinal dysbiosis …. A donor effect which could be related to the inter-individual variability of microbiota and microbiome leading to specific metabolic capacities may influence the efficacy of the procedure.

NCT ID: NCT03527056 Withdrawn - Clinical trials for Fecal Microbiota Transplantation

Pilot Study Using Oral Capsule FMT to Decolonize GI CRE

Start date: June 2019
Phase: Early Phase 1
Study type: Interventional

Carbapenem-Resistant Enterobacteriaceae (CRE) are bacteria that have become resistant to carbapenems by producing enzymes that break down carbapenems. The prevalence of CRE continues to rise globally but the treatment options are extremely limited. In case series, isolation of CRE from any site, whether there is clinical infection or not, has been associated with all-cause hospital mortality ranging from 29% to 52%. There are no known methods for reliably decolonizing gastrointestinal (GI) CRE. In rare case reports, fecal microbiota transplant (FMT) has successfully eradicated gastrointestinal colonization of CRE, but there has been no larger study further investigating this. FMT via oral capsules is the least invasive method and has demonstrated efficacy and short-term safety in treating patients with recurrent Clostridium difficile infections. Therefore, the investigators propose this pilot study to determine the effectiveness of oral capsule fecal transplantation in the decolonization of gastrointestinal CRE.